T1	Participants 341 391	individuals with chronic renal insufficiency (CRI)
T2	Participants 638 662	people with moderate CRI
T3	Participants 1415 1465	1,981 individuals, of whom 399 individuals (20.2%)
T4	Participants 1501 1519	399 study subjects
